Mex$0.25
99.04%
Mexican, Oct 01, 07:30 am CST.
Why the stock moved Why the stock moved Beta
ISIN
MXP3895X1106
Symbol
BEVIDESB

Farmacias Benavides-series B Stock price

Mex$26.00
+0.00 0.00% 1M
+0.00 0.00% 6M
+0.00 0.00% YTD
+1.00 4.00% 1Y
+8.00 44.44% 3Y
+12.81 97.12% 5Y
+14.00 116.67% 10Y
+21.00 420.00% 20Y
Mexican, Closing price Wed, Sep 23 2026
+0.00 0.00%
ISIN
MXP3895X1106
Symbol
BEVIDESB

Is Farmacias Benavides-series B a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,120 stocks worldwide.

Key metrics

Basic
Market capitalization
Mex$9.0b
Enterprise Value
Mex$11.5b
Net debt
Mex$2.5b
Cash
Mex$419.9m
Shares outstanding
408.8m
Valuation
P/E
32.1
P/S | estimate
0.4 | -
EV/Sales | estimate
0.5 | -
EV/FCF | ex SBC
7.6 | -
P/B
8.5
Financial Health
Equity Ratio
7.8%
Return on Equity
29.5%
ROCE
30.3%
ROIC
14.6%
Debt/Equity
2.8
Financials
Revenue | estimate
Mex$21.6b | -
EBITDA
Mex$2.3b
EBIT
Mex$1.1b
Net Income
Mex$329.1m
Free Cash Flow | ex SBC
Mex$1.5b | -
Growth
Revenue | estimate
21.8% | -
EBITDA
21.2%
EBIT
26.9%
Net Income
69.0%
Free Cash Flow
11.6%
Margin
Gross
28.6%
EBITDA
10.8%
EBIT
5.1%
Net
1.5%
Free Cash Flow | ex SBC
6.9% | -
More
EPS
Mex$0.8
FCF per Share
Mex$3.7
Short interest
-
Employees
8k
Rev per Employee
Mex$2.4m

Financial data from Farmacias Benavides-series B

Jun '26
+/-
%
21,630 21,630
22% 22%
100%
- Direct Costs 15,436 15,436
27% 27%
71%
6,194 6,194
10% 10%
29%
- Selling and Administrative Expenses 5,088 5,088
7% 7%
24%
- Research and Development Expense - -
-
-
2,326 2,326
21% 21%
11%
- Depreciation and Amortization 1,220 1,220
17% 17%
6%
EBIT (Operating Income) EBIT 1,106 1,106
27% 27%
5%
Net Profit 329 329
69% 69%
2%

In millions MXN.

Don't miss a Thing! We will send you all news about Farmacias Benavides-series B directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Farmacias Benavides SAB de CV engages in the retail of pharmaceutical products and operation of pharmacies. The company is headquartered in Monterrey, Nuevo Leon. The firm operates a network of over 700 drug stores located nationwide under the Farmacias Benavides name. Through its network of drug stores, it sells a variety prescription and over the counter (OTC) medicines, cosmetics, personal and baby care products and toiletries, as well as it also provides such related services as laboratory samples, home delivery, prescription laboratory, online pharmacy and photo processing services. As of December 31, 2011, the Company owned such subsidiaries as Servicios Operacionales Benavides SA de CV, Benavides de Reynosa SA de CV and Servicios Logisticos Benavides SA de CV, and Fasa Investment Limitada which was its majority shareholder with 85.25% of its interest.

Head office Mexico
CEO Mr. Gutierrez-Lascurain
Employees 8,023
Website www.benavides.com.mx

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today